SGLT2 inhibitors as a treatment option in heart failure

There is a need for treatments that improve outcomes for patients with HF. This module details available evidence for SGLT2 inhibitors in patients with HF, and potential SGLT2 inhibitor mechanisms that may have beneficial effects for HF.

 

SGLT2 inhibitors as a treatment option in heart failure
Rate this content
  • SGLT2 inhibitors as a treatment option in heart failure
  • Contents
  • Heart failure poses a significant global disease burden
  • There remains an opportunity for treatments that improve outcomes for patients with heart failure
  • Heart failure has wide clinical implications, including the potential for kidney damage
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go